BIOACTIVE SMALL MOLECULES; MYOTONIC-DYSTROPHY TYPE-1; DESIGNED SMALL MOLECULES; SEQUENCE-BASED DESIGN; TARGETING RNA; PLASMINOGEN-ACTIVATOR; DRUG DISCOVERY; RECOGNITION; INHIBITORS; COMPLEX
MEDCHEMCOMM, v.8, no.5, pp.1022 - 1036
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.